BTK
BTK (Bruton's tyrosine kinase) inhibitors are compounds that specifically target and inhibit BTK, a crucial enzyme involved in B-cell receptor signaling and the regulation of angiogenesis. BTK plays a significant role in the proliferation and survival of cancer cells, particularly in hematological malignancies. By inhibiting BTK, these compounds can disrupt angiogenesis and tumor growth, making them valuable in cancer therapy. At CymitQuimica, we offer a range of high-quality BTK inhibitors to support your research in oncology, immunology, and angiogenesis.
Read more
Pirtobrutinib
CAS:2101700-15-4
Pirtobrutinib: a selective, non-covalent BTK inhibitor effective against BTK C481 mutations, causing tumor regression in …
Formula:
C22H21F4N5O3
Purity:
99.76% - 99.94%
Color and Shape:
Solid
Molecular weight:
479.43
Ref: TM-T36287
| 1mg | 37.00 € | ||
| 5mg | 79.00 € | ||
| 10mg | 126.00 € | ||
| 25mg | 283.00 € | ||
| 50mg | 434.00 € | ||
| 100mg | 638.00 € | ||
| 500mg | 1,359.00 € | ||
| 1mL*10mM (DMSO) | 84.00 € |
Estimated delivery in United States, on Friday 11 Jul 2025
BTK-IN-25
CAS:2562351-92-0
BTK-IN-25 (compound 71) is a potent BTK inhibitor, demonstrating an IC50 of 0.77 nM against …
Formula:
C28H27F2N3O5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
523.53
Ref: TM-T79113
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 11 Jul 2025
Edralbrutinib
CAS:1858206-58-2
Edralbrutinib (TG-1701) is a potent BTK inhibitor with anticancer activity and is used in the …
Formula:
C26H21F2N5O3
Purity:
99.47%
Color and Shape:
Liquid
Molecular weight:
489.47
Ref: TM-T63272
| 1mg | 187.00 € | ||
| 5mg | 464.00 € | ||
| 10mg | 747.00 € | ||
| 25mg | 1,254.00 € | ||
| 50mg | 1,691.00 € | ||
| 100mg | 2,270.00 € |
Estimated delivery in United States, on Friday 11 Jul 2025
BTK-IN-27
CAS:1841502-36-0
BTK-IN-27 (example 8), a potent BTK inhibitor with an IC50 of 0.2 nM, demonstrates anti-proliferative …
Formula:
C31H35N7O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
537.66
Ref: TM-T79812
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 11 Jul 2025
BTK-IN-16
CAS:2883232-92-4
BTK-IN-16 is a potential inhibitor of wild-type BTK and C481S mutants.BTK-IN-16 can be used to …
Formula:
C15H14N4O2
Purity:
99.04%
Color and Shape:
Soild
Molecular weight:
282.3
Ref: TM-T60542
| 1mg | 333.00 € | ||
| 5mg | 922.00 € | ||
| 10mg | 1,140.00 € | ||
| 25mg | 1,510.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € |
Estimated delivery in United States, on Friday 8 Aug 2025
WS-11
CAS:2759280-09-4
WS-11 is a non-covalent reversible inhibitor of BTK, with IC50 values of 3.9 nM for …
Formula:
C26H22FN9O2
Color and Shape:
Solid
Molecular weight:
511.51
Ref: TM-T201126
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 8 Aug 2025
BTK-IN-38
CAS:2758410-51-2
BTK-IN-38 (Example 125) is an efficacious inhibitor of BTK. It effectively suppresses the proliferation of …
Formula:
C27H26F2N4O2
Color and Shape:
Solid
Molecular weight:
476.52
Ref: TM-T201231
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 8 Aug 2025
G-744
CAS:1346669-54-2
G-744 is a selective and orally active inhibitor of Btk (IC50: 2 nM).
Formula:
C29H29N5O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
527.64
Ref: TM-T15365
| 25mg | 3,012.00 € | ||
| 50mg | 3,971.00 € | ||
| 100mg | 5,510.00 € |
Estimated delivery in United States, on Friday 8 Aug 2025
BIIB129
CAS:2770960-52-4
BIIB129 is a selective and brain-penetrant BTK covalent inhibitor used to study B-cell proliferation-related diseases.
Formula:
C19H22N6O2
Purity:
98.56%
Color and Shape:
Solid
Molecular weight:
366.42
Ref: TM-T88336
| 1mg | 70.00 € | ||
| 5mg | 154.00 € | ||
| 10mg | 210.00 € | ||
| 25mg | 359.00 € | ||
| 50mg | 540.00 € | ||
| 100mg | 755.00 € | ||
| 200mg | 1,017.00 € |
Estimated delivery in United States, on Friday 8 Aug 2025
